| Document | Type | Published |
|---|---|---|
| Respiratory System | Prescribing Data Report | August 2026 |
| Cost Comparison Charts | Cost comparison charts | August 2026 |
| Inhaler Carbon Impact Assessment Tool | Prescribing Data Report | November 2025 |
| Inhaler Carbon Footprint – MO opportunities | Prescribing Data Report | November 2025 |
| NHS Medicines Optimisation Opportunities Dashboard | Prescribing Data Report | May 2025 |
| Budget impact of acetylcysteine vs carbocisteine | Prescribing bulletin | March 2024 |
| Sustainability: Environmental impact of inhaler disposal | Prescribing bulletin | August 2023 |
| Considerations for Sustainable Inhaler Prescribing | Medicines in Practice | March 2023 |
| Reducing the carbon impact of inhalers across the North of England | Prescribing bulletin | September 2021 |
| Omalizumab and dupilumab for chronic rhinosinusitis with nasal polyps | Evaluation report | September 2021 |
